clinical trialWestern Institutional Review Board (WIRB), the world’s leading provider of ethical review of clinical research, has announced the launch of its WIRB NIH Single Review Solution (SRS) for NIH-funded multisite research.

As the longstanding leader in supporting IRB reviews among its 2300 institution clients, WIRB has an extensive background in reviewing clinical trials funded by NIH.

Building upon our trusted status as the IRB of record for the majority of institutions that conduct clinical research in the US, our WIRB NIH Single Review Solution will provide participating institutions the gold standard of research review that has made WIRB the trusted leader to institutions for more than 40 years.

Starting in September of 2017, NIH’s new policy directing a Single Review Mandate for multicentre clinical trials becomes effective. This mandate applies to research funded by NIH and is intended to improve the overall efficiency of managing clinical research grants.

The WIRB NIH Single Review Solution assures that participating institutions will comply with the requirements of the NIH Single Review Mandate without the expense and challenges of establishing a central IRB.

The advantages of this affordable and easy-to-implement solution includes WIRB review and oversight, co-ordination of site submissions and vital communications, accurate budgeting for IRB review of multiyear studies, all accompanied by the support of our review professionals who will ease the administrative burdens on your study staff by providing the necessary co-ordination and communication with all of the participating sites.

WIRB has combined the trusted track record of its people, process and technology to provide one solution to make it less burdensome for investigators and institutions to plan, submit and conduct their NIH-funded studies as efficiently, compliantly and as safely as possible.

“Most Academic Medical Centers and participating institutions may have a steep learning curve to fully comply with the NIH single-IRB review mandate,” said Stuart Horowitz, PhD, MBA, President of Institutions for the WIRB-Copernicus IRB Group.

“We have developed the WIRB NIH Single Review Solution specifically to help participating organisations comply with the new policy and to understand the myriad issues inherent in acting as the IRB of record on these grants – a service WIRB has been providing institutions since 1968.”